Yoshiaki Yura Selected Research

Yoshiaki Yura Research Topics

Disease

20	Squamous Cell Carcinoma of Head and Neck 02/2022 - 05/2004
18	Neoplasms (Cancer) 02/2022 - 05/2004
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 03/2008
4	Infections 09/2020 - 03/2008
3	Melanoma (Melanoma, Malignant) 09/2020 - 02/2005
3	Lymphatic Metastasis 10/2015 - 09/2012
2	Carcinogenesis 11/2010 - 12/2005
1	Neoplasm Metastasis (Metastasis) 02/2022
1	Vesicular Stomatitis 09/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2020
1	Mouth Neoplasms (Oral Cancer) 05/2017
1	Necrosis 01/2017
1	Pleomorphic Adenoma 01/2016
1	Adenoid Cystic Carcinoma (Cylindroma) 07/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Apnea 06/2010
1	Trismus (Lockjaw) 06/2010
1	Osteoarthritis 06/2010
1	Pneumonia (Pneumonitis) 06/2010
1	Brain Neoplasms (Brain Tumor) 12/2009
1	Mediastinal Emphysema (Pneumomediastinum) 02/2009
1	Subcutaneous Emphysema 02/2009
1	Retinoblastoma (Glioblastoma, Retinal) 03/2008
1	Cleft Lip (Harelip) 03/2007
1	Herpesviridae Infections (Herpesvirus Infection) 03/2006
1	Dental Plaque 02/2006
1	Bone Resorption 02/2005
1	Carcinoma (Carcinomatosis) 10/2004
1	Hyperplasia 10/2004
1	Cysts 05/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2004
3	safingol (sphinganine)IBA 01/2016 - 03/2009
3	Vascular Endothelial Growth Factor CIBA 10/2015 - 07/2011
2	EnzymesIBA 07/2020 - 02/2006
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016 - 07/2011
2	endonuclease GIBA 01/2016 - 02/2014
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2012 - 07/2002
2	NF-kappa B (NF-kB)IBA 01/2011 - 07/2002
1	Immune Checkpoint InhibitorsIBA 02/2022
1	AntibodiesIBA 02/2022
1	Anti-Infective Agents (Microbicides)IBA 09/2020
1	Penicillins (Penicillin)FDA Link 09/2020
1	SphingosineIBA 07/2020
1	CeramidesIBA 07/2020
1	Viral ProteinsIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 05/2017
1	sphingosine kinaseIBA 01/2017
1	PF-543IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Collagen Type II (Type II Collagen)IBA 01/2016
1	Aggrecans (Aggrecan)IBA 01/2016
1	Fibronectins (Fibronectin)IBA 10/2015
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2014
1	Biological ProductsIBA 01/2014
1	SodiumIBA 12/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2012
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 09/2012
1	geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA 09/2011
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2011
1	Vascular Endothelial Growth Factor DIBA 07/2011
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	Glycogen Synthase (Synthase I)IBA 11/2010
1	CateninsIBA 11/2010
1	Complementary DNA (cDNA)IBA 11/2010
1	Protein Kinase CIBA 03/2009
1	CollagenIBA 08/2008
1	vesicular stomatitis virus G proteinIBA 03/2008
1	MouthwashesIBA 02/2006
1	Sucrose (Saccharose)IBA 02/2006
1	Acetazolamide (Diamox)FDA LinkGeneric 02/2006
1	carbonic anhydrase VI (gustin)IBA 02/2006
1	Bromodeoxyuridine (BrdU)IBA 01/2006
1	beta CateninIBA 12/2005
1	Cisplatin (Platino)FDA LinkGeneric 05/2005
1	titanium silicide (TS-1)IBA 05/2005
1	Diphosphonates (Bisphosphonates)IBA 02/2005
1	Tartrate-Resistant Acid PhosphataseIBA 02/2005
1	cimadronateIBA 02/2005
1	Dihydrotachysterol (AT 10)IBA 10/2004
1	Oncogene Proteins (Oncogene Protein)IBA 10/2004
1	mercaptoundecahydrododecaborate (borocaptate sodium)IBA 05/2004
1	Keratins (Keratin)IBA 05/2004
1	Boron CompoundsIBA 05/2004
1	BoronIBA 05/2004

Therapy/Procedure

7	Boron Neutron Capture Therapy 12/2013 - 05/2004
5	Drug Therapy (Chemotherapy) 02/2022 - 05/2005
5	Radiotherapy 07/2020 - 05/2004
4	Oncolytic Virotherapy 05/2017 - 11/2008
3	Therapeutics 02/2022 - 05/2017
1	Immunotherapy 09/2020
1	Airway Management 04/2014
1	Microbubbles 12/2013
1	Cannula 06/2010
1	Tracheostomy 06/2010
1	Lasers (Laser) 02/2009
1	Neutron Capture Therapy 03/2008
1	Distraction Osteogenesis 03/2007
1	Oral Surgery (Maxillofacial Surgery) 03/2006